These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38573193)

  • 21. Redox interactions between catalase and alcohol dehydrogenase pathways of ethanol metabolism in the perfused rat liver.
    Handler JA; Thurman RG
    J Biol Chem; 1990 Jan; 265(3):1510-5. PubMed ID: 2295642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Under peroxisome proliferation acyl-CoA oxidase coordinates with catalase to enhance ethanol metabolism.
    Chen X; Denning KL; Mazur A; Lawrence LM; Wang X; Lu Y
    Free Radic Biol Med; 2023 Nov; 208():221-228. PubMed ID: 37567517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PPARα agonist WY-14,643 enhances ethanol metabolism in mice: Role of catalase.
    Chen X; Xu Y; Denning KL; Grigore A; Lu Y
    Free Radic Biol Med; 2021 Jun; 169():283-293. PubMed ID: 33892114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microsomal ethanol-oxidizing system (MEOS): the first 30 years (1968-1998)--a review.
    Lieber CS
    Alcohol Clin Exp Res; 1999 Jun; 23(6):991-1007. PubMed ID: 10397283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of microsomal cytochrome b5 in the metabolism of ethanol, drugs and the desaturation of fatty acids.
    Ozols J
    Ann Clin Res; 1976; 8 Suppl 17():182-92. PubMed ID: 12714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Translational Implications of the Alcohol-Metabolizing Enzymes, Including Cytochrome P450-2E1, in Alcoholic and Nonalcoholic Liver Disease.
    Song BJ; Akbar M; Jo I; Hardwick JP; Abdelmegeed MA
    Adv Pharmacol; 2015; 74():303-72. PubMed ID: 26233911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic basis of ethanol-induced cytotoxicity in recombinant HepG2 cells: role of nonoxidative metabolism.
    Wu H; Cai P; Clemens DL; Jerrells TR; Ansari GA; Kaphalia BS
    Toxicol Appl Pharmacol; 2006 Oct; 216(2):238-47. PubMed ID: 16806343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peroxisomal beta-oxidation and steatohepatitis.
    Rao MS; Reddy JK
    Semin Liver Dis; 2001; 21(1):43-55. PubMed ID: 11296696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significance of catalase in peroxisomal fatty acyl-CoA beta-oxidation: NADH oxidation by acetoacetyl-CoA and H2O2.
    Hashimoto F; Hayashi H
    J Biochem; 1990 Sep; 108(3):426-31. PubMed ID: 2277034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rates of H2O2 generation from peroxisomal beta-oxidation are sufficient to account for fatty acid-stimulated ethanol metabolism in perfused rat liver.
    Handler JA; Thurman RG
    Alcohol; 1987; 4(2):131-4. PubMed ID: 3580135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dietary saturated fat reduces alcoholic hepatotoxicity in rats by altering fatty acid metabolism and membrane composition.
    Ronis MJ; Korourian S; Zipperman M; Hakkak R; Badger TM
    J Nutr; 2004 Apr; 134(4):904-12. PubMed ID: 15051845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease.
    Leung TM; Nieto N
    J Hepatol; 2013 Feb; 58(2):395-8. PubMed ID: 22940046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Clomethiazole Vs. Clorazepate on Hepatic Fat and Serum Transaminase Activities in Alcohol-Associated Liver Disease: Results from a Randomized, Controlled Phase II Clinical Trial.
    Hohmann N; Schröder F; Moreira B; Teng H; Burhenne J; Bruckner T; Mueller S; Haefeli WE; Seitz HK
    Alcohol Alcohol; 2023 Mar; 58(2):134-141. PubMed ID: 36562601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. H
    Chen C; Wang S; Yu L; Mueller J; Fortunato F; Rausch V; Mueller S
    Redox Biol; 2021 Oct; 46():102081. PubMed ID: 34343907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alcoholic Liver Disease: Alcohol Metabolism, Cascade of Molecular Mechanisms, Cellular Targets, and Clinical Aspects.
    Teschke R
    Biomedicines; 2018 Nov; 6(4):. PubMed ID: 30424581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of chronic alcohol consumption on ethanol and acetaldehyde metabolism.
    Lieber CS; DeCarli LM; Feinman L; Hasumura Y; Korsten M; Matsuzaki S; Teschke R
    Adv Exp Med Biol; 1975; 59():185-227. PubMed ID: 241214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis.
    Lieber CS
    Alcohol; 2004 Aug; 34(1):9-19. PubMed ID: 15670660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of the peroxisome proliferator-activated receptor gene is decreased in experimental alcoholic liver disease.
    Wan YJ; Morimoto M; Thurman RG; Bojes HK; French SW
    Life Sci; 1995; 56(5):307-17. PubMed ID: 7837930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of oxidative stress and antioxidant therapy in alcoholic and nonalcoholic liver diseases.
    Lieber CS
    Adv Pharmacol; 1997; 38():601-28. PubMed ID: 8895826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system.
    Reddy JK; Hashimoto T
    Annu Rev Nutr; 2001; 21():193-230. PubMed ID: 11375435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.